Efficacy And Tolerability Of Simeprevir And Daclatasvir For 12 Or 24 Weeks In Hcv Genotype 1b-Infected Treatment-Naive Patients With Advanced Fibrosis Or Compensated Cirrhosis

JOURNAL OF HEPATOLOGY(2016)

引用 5|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要